Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001781067 | SCV002024541 | likely pathogenic | Retinitis pigmentosa 25 | 2021-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003772150 | SCV004660396 | pathogenic | not provided | 2023-12-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro1385Argfs*2) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with EYS-related conditions. ClinVar contains an entry for this variant (Variation ID: 1324362). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001781067 | SCV005060462 | likely pathogenic | Retinitis pigmentosa 25 | 2024-03-16 | criteria provided, single submitter | clinical testing |